Literature DB >> 27223121

Epigenetic regulation of SMARCB1 By miR-206, -381 and -671-5p is evident in a variety of SMARCB1 immunonegative soft tissue sarcomas, while miR-765 appears specific for epithelioid sarcoma. A miRNA study of 223 soft tissue sarcomas.

Zoltán Sápi1, Gergő Papp1, Miklós Szendrői2, Zsuzsanna Pápai3, Vanda Plótár4, Thomas Krausz5, Christopher D M Fletcher6.   

Abstract

Complete/partial loss of SMARCB1 nuclear-immunopositivity is characteristic of a certain subset of soft tissue sarcomas (STSs). Our previous work showed that oncomiRs-206,-381, and 671-5p could silence the SMARCB1 mRNA and protein expression and that they display significant overexpression in epithelioid sarcomas (ESs). MiR-765 was overexpressed too, but functionally was inactive in the silencing. In the current work, using quantitative PCR, we conducted a miRNA study of 51 ESs, 20 rhabdoid tumors (RTs), 20 synovial sarcomas (SSs), 15 malignant peripheral nerve sheath tumors (MPNSTs), 11 myoepithelial carcinomas (MECs), and 10 extraskeletal myxoid chondrosarcomas (EMCSs) with complete/partial loss of SMARCB1 nuclear immunostain, in contrast to controls (SMARCB1-immunopositive) of 96 STSs, 13 melanomas and 10 sarcomatoid carcinomas. The SMARCB1 genetic status of ESs was determined by MLPA and FISH. A subset of ESs (5/51) showed biallelic deletion of SMARCB1 with no overexpression of any miRNA, suggesting these tumors could be the counterpart of pediatric RT, at least genetically. Another subset (5/51) was genetically either intact or monoallelic deleted with at least threefold overexpression of one of miR-206,-381,-671-5p, suggesting epigenetic regulation only. 39/51 ESs had a biallelic deletion (>20% by FISH and/or by MLPA) but with overexpressed miR-206,-381, and 671-5p, suggesting intratumoral heterogeneity, i.e., both genetic and epigenetic regulation. At least threefold overexpression of one of miR-206,-381, and 671-5p was detected in all MPNSTs, EMCSs, SSs and 7 MCs. Except for ESs, four SSs and one MPNST, there was no event above threefold overexpression of miR-765 among all 195 tested tumors. Our results suggest a general role of miR-206,-381, and 671-5p in SMARCB1 gene silencing of ES, MC, EMCS, MPNST and SS. In the future, miR-765 could possibly be a diagnostic tool for ES because of its 97% specificity and 80% sensitivity.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27223121     DOI: 10.1002/gcc.22379

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  20 in total

1.  Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas.

Authors:  Inga-Marie Schaefer; Abbas Agaimy; Christopher Dm Fletcher; Jason L Hornick
Journal:  Mod Pathol       Date:  2017-01-13       Impact factor: 7.842

2.  MicroRNAs association with azoospermia, oligospermia, asthenozoospermia, and teratozoospermia: a systematic review.

Authors:  Yousef Daneshmandpour; Zahra Bahmanpour; Hamid Hamzeiy; Marziyeh Mazaheri Moghaddam; Madiheh Mazaheri Moghaddam; Bahareh Khademi; Ebrahim Sakhinia
Journal:  J Assist Reprod Genet       Date:  2020-03-18       Impact factor: 3.412

3.  MicroRNA expression in SMARCB1/INI1-deficient sinonasal carcinoma: a clinicopathological and molecular genetic study.

Authors:  Jan Laco; Helena Kovaříková; Marcela Chmelařová; Hana Vošmiková; Kateřina Sieglová; Ivana Baranová; Pavel Dundr; Kristýna Němejcová; Jaroslav Michálek; Jana Šatanková; Milan Vošmik; Aleš Ryška
Journal:  Virchows Arch       Date:  2018-01-11       Impact factor: 4.064

Review 4.  What is new in epithelioid soft tissue tumors?

Authors:  Abbas Agaimy
Journal:  Virchows Arch       Date:  2019-11-04       Impact factor: 4.064

5.  The oncomir face of microRNA-206: A permanent miR-206 transfection study.

Authors:  Dóra Mihály; Gergő Papp; Zsolt Mervai; Andrea Reszegi; Péter Tátrai; Gábor Szalóki; Johanna Sápi; Zoltán Sápi
Journal:  Exp Biol Med (Maywood)       Date:  2018-08-15

6.  Recurrent SMARCB1 Inactivation in Epithelioid Malignant Peripheral Nerve Sheath Tumors.

Authors:  Inga-Marie Schaefer; Fei Dong; Elizabeth P Garcia; Christopher D M Fletcher; Vickie Y Jo
Journal:  Am J Surg Pathol       Date:  2019-06       Impact factor: 6.394

7.  High sensitivity of FISH analysis in detecting homozygous SMARCB1 deletions in poorly differentiated chordoma: a clinicopathologic and molecular study of nine cases.

Authors:  Adepitan A Owosho; Lei Zhang; Marc K Rosenblum; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2017-11-23       Impact factor: 5.006

8.  MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression.

Authors:  Zhaozhou Ren; Ming He; Tao Shen; Kejia Wang; Qingjie Meng; Xiangxu Chen; Long Zhou; Yanshuo Han; Chao Ji; Shengnan Liu; Qin Fu
Journal:  Cancer Biol Ther       Date:  2019-11-12       Impact factor: 4.742

9.  Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas.

Authors:  Snjezana Dogan; Paolo Cotzia; Ryan N Ptashkin; Gouri J Nanjangud; Bin Xu; Amir Momeni Boroujeni; Marc A Cohen; David G Pfister; Manju L Prasad; Cristina R Antonescu; Yingbei Chen; Mrinal M Gounder
Journal:  Hum Pathol       Date:  2020-08-18       Impact factor: 3.466

Review 10.  Immunohistochemical Biomarkers of Mesenchymal Neoplasms in Endocrine Organs: Diagnostic Pitfalls and Recent Discoveries.

Authors:  Yin P Hung; Jason L Hornick
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.